Does the media refer more to MMED or BLFS?

In the previous week, BioLife Solutions had 9 more articles in the media than MiniMed Group. MarketBeat recorded 23 mentions for BioLife Solutions and 14 mentions for MiniMed Group. BioLife Solutions' average media sentiment score of 0.77 beat MiniMed Group's score of 0.12 indicating that BioLife Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 12 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BioLife Solutions 6 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to LIVN or BLFS?

In the previous week, BioLife Solutions had 17 more articles in the media than LivaNova. MarketBeat recorded 23 mentions for BioLife Solutions and 6 mentions for LivaNova. LivaNova's average media sentiment score of 1.02 beat BioLife Solutions' score of 0.77 indicating that LivaNova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioLife Solutions 6 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BLFS or NVST?

In the previous week, BioLife Solutions had 20 more articles in the media than Envista. MarketBeat recorded 23 mentions for BioLife Solutions and 3 mentions for Envista. Envista's average media sentiment score of 1.69 beat BioLife Solutions' score of 0.77 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 6 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to IRTC or BLFS?

In the previous week, BioLife Solutions had 13 more articles in the media than iRhythm Technologies. MarketBeat recorded 23 mentions for BioLife Solutions and 10 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.85 beat BioLife Solutions' score of 0.77 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioLife Solutions 6 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BLFS or ESTA?

In the previous week, BioLife Solutions had 17 more articles in the media than Establishment Labs. MarketBeat recorded 23 mentions for BioLife Solutions and 6 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.11 beat BioLife Solutions' score of 0.77 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 6 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Establishment Labs 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

BioLife Solutions (BLFS) Competitors

$29.98 -0.79 (-2.57%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$30.20 +0.22 (+0.73%)

As of 07/24/2026 07:34 PM Eastern

Compare

BLFS vs. MMED, LIVN, NVST, IRTC, and ESTA

Should you buy BioLife Solutions stock or one of its competitors? MarketBeat compares BioLife Solutions with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BioLife Solutions include MiniMed Group (MMED), LivaNova (LIVN), Envista (NVST), iRhythm Technologies (IRTC), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.

How does BioLife Solutions compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and BioLife Solutions (NASDAQ:BLFS) are both medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

BioLife Solutions has lower revenue, but higher earnings than MiniMed Group. BioLife Solutions is trading at a lower price-to-earnings ratio than MiniMed Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.10B	1.52	-$190.97M	-$0.68	N/A
BioLife Solutions	$96.21M	15.23	-$4.59M	-$0.08	N/A

MiniMed Group has a net margin of 0.00% compared to BioLife Solutions' net margin of -2.80%. BioLife Solutions' return on equity of 1.81% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
BioLife Solutions	-2.80%	1.81%	1.65%

In the previous week, BioLife Solutions had 9 more articles in the media than MiniMed Group. MarketBeat recorded 23 mentions for BioLife Solutions and 14 mentions for MiniMed Group. BioLife Solutions' average media sentiment score of 0.77 beat MiniMed Group's score of 0.12 indicating that BioLife Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	12 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
BioLife Solutions	6 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MiniMed Group presently has a consensus price target of $21.33, indicating a potential upside of 26.76%. BioLife Solutions has a consensus price target of $31.43, indicating a potential upside of 4.83%. Given MiniMed Group's stronger consensus rating and higher probable upside, equities analysts clearly believe MiniMed Group is more favorable than BioLife Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73
BioLife Solutions	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

19.7% of MiniMed Group shares are held by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are held by institutional investors. 2.2% of MiniMed Group shares are held by company insiders. Comparatively, 2.2% of BioLife Solutions shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

BioLife Solutions beats MiniMed Group on 9 of the 15 factors compared between the two stocks.

How does BioLife Solutions compare to LivaNova?

LivaNova (NASDAQ:LIVN) and BioLife Solutions (NASDAQ:BLFS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

In the previous week, BioLife Solutions had 17 more articles in the media than LivaNova. MarketBeat recorded 23 mentions for BioLife Solutions and 6 mentions for LivaNova. LivaNova's average media sentiment score of 1.02 beat BioLife Solutions' score of 0.77 indicating that LivaNova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BioLife Solutions	6 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LivaNova has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, BioLife Solutions has a beta of 1.94, suggesting that its share price is 94% more volatile than the broader market.

BioLife Solutions has lower revenue, but higher earnings than LivaNova. BioLife Solutions is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.43B	3.00	-$242.47M	$1.95	40.10
BioLife Solutions	$96.21M	15.23	-$4.59M	-$0.08	N/A

97.6% of LivaNova shares are held by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are held by institutional investors. 0.4% of LivaNova shares are held by insiders. Comparatively, 2.2% of BioLife Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

LivaNova currently has a consensus target price of $81.38, indicating a potential upside of 4.07%. BioLife Solutions has a consensus target price of $31.43, indicating a potential upside of 4.83%. Given BioLife Solutions' higher possible upside, analysts plainly believe BioLife Solutions is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
BioLife Solutions	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

LivaNova has a net margin of 7.48% compared to BioLife Solutions' net margin of -2.80%. LivaNova's return on equity of 16.48% beat BioLife Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	7.48%	16.48%	7.59%
BioLife Solutions	-2.80%	1.81%	1.65%

Summary

LivaNova beats BioLife Solutions on 11 of the 17 factors compared between the two stocks.

How does BioLife Solutions compare to Envista?

BioLife Solutions (NASDAQ:BLFS) and Envista (NYSE:NVST) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and risk.

BioLife Solutions has a beta of 1.94, suggesting that its share price is 94% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market.

Envista has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLife Solutions	$96.21M	15.23	-$4.59M	-$0.08	N/A
Envista	$2.81B	1.53	$47M	$0.41	64.26

93.2% of BioLife Solutions shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by insiders. Comparatively, 1.0% of Envista shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, BioLife Solutions had 20 more articles in the media than Envista. MarketBeat recorded 23 mentions for BioLife Solutions and 3 mentions for Envista. Envista's average media sentiment score of 1.69 beat BioLife Solutions' score of 0.77 indicating that Envista is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioLife Solutions	6 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Envista has a net margin of 2.41% compared to BioLife Solutions' net margin of -2.80%. Envista's return on equity of 7.11% beat BioLife Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLife Solutions	-2.80%	1.81%	1.65%
Envista	2.41%	7.11%	3.91%

BioLife Solutions presently has a consensus target price of $31.43, indicating a potential upside of 4.83%. Envista has a consensus target price of $28.54, indicating a potential upside of 8.33%. Given Envista's stronger consensus rating and higher probable upside, analysts plainly believe Envista is more favorable than BioLife Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLife Solutions	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

Summary

Envista beats BioLife Solutions on 11 of the 16 factors compared between the two stocks.

How does BioLife Solutions compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and BioLife Solutions (NASDAQ:BLFS) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

BioLife Solutions has a net margin of -2.80% compared to iRhythm Technologies' net margin of -3.53%. BioLife Solutions' return on equity of 1.81% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
BioLife Solutions	-2.80%	1.81%	1.65%

93.2% of BioLife Solutions shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by insiders. Comparatively, 2.2% of BioLife Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

iRhythm Technologies has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, BioLife Solutions has a beta of 1.94, indicating that its share price is 94% more volatile than the broader market.

BioLife Solutions has lower revenue, but higher earnings than iRhythm Technologies. BioLife Solutions is trading at a lower price-to-earnings ratio than iRhythm Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.80	-$44.55M	-$0.86	N/A
BioLife Solutions	$96.21M	15.23	-$4.59M	-$0.08	N/A

iRhythm Technologies currently has a consensus target price of $184.71, suggesting a potential upside of 69.15%. BioLife Solutions has a consensus target price of $31.43, suggesting a potential upside of 4.83%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts clearly believe iRhythm Technologies is more favorable than BioLife Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	3 Strong Buy rating(s)	3.00
BioLife Solutions	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, BioLife Solutions had 13 more articles in the media than iRhythm Technologies. MarketBeat recorded 23 mentions for BioLife Solutions and 10 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.85 beat BioLife Solutions' score of 0.77 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BioLife Solutions	6 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BioLife Solutions beats iRhythm Technologies on 10 of the 17 factors compared between the two stocks.

How does BioLife Solutions compare to Establishment Labs?

BioLife Solutions (NASDAQ:BLFS) and Establishment Labs (NASDAQ:ESTA) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

BioLife Solutions has a net margin of -2.80% compared to Establishment Labs' net margin of -19.05%. BioLife Solutions' return on equity of 1.81% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioLife Solutions	-2.80%	1.81%	1.65%
Establishment Labs	-19.05%	-218.77%	-12.31%

93.2% of BioLife Solutions shares are held by institutional investors. Comparatively, 72.9% of Establishment Labs shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by company insiders. Comparatively, 10.0% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

BioLife Solutions has a beta of 1.94, meaning that its stock price is 94% more volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.06, meaning that its stock price is 6% more volatile than the broader market.

BioLife Solutions presently has a consensus target price of $31.43, suggesting a potential upside of 4.83%. Establishment Labs has a consensus target price of $90.43, suggesting a potential downside of 2.05%. Given BioLife Solutions' higher possible upside, equities research analysts clearly believe BioLife Solutions is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLife Solutions	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

BioLife Solutions has higher earnings, but lower revenue than Establishment Labs. BioLife Solutions is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLife Solutions	$96.21M	15.23	-$4.59M	-$0.08	N/A
Establishment Labs	$229.58M	11.83	-$51.06M	-$1.49	N/A

In the previous week, BioLife Solutions had 17 more articles in the media than Establishment Labs. MarketBeat recorded 23 mentions for BioLife Solutions and 6 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.11 beat BioLife Solutions' score of 0.77 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioLife Solutions	6 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Establishment Labs	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BioLife Solutions beats Establishment Labs on 10 of the 16 factors compared between the two stocks.

Get BioLife Solutions News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BLFS vs. The Competition

Export

Metric	BioLife Solutions	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.50B	$8.68B	$6.88B	$12.25B
Dividend Yield	N/A	2.52%	2.67%	9.79%
P/E Ratio	-374.70	18.51	27.00	23.71
Price / Sales	15.23	7.24	492.66	73.79
Price / Cash	134.38	18.17	50.54	59.64
Price / Book	3.88	3.19	10.28	6.07
Net Income	-$4.59M	$230.22M	$3.60B	$331.84M
7 Day Performance	2.85%	21.69%	-1.25%	-1.53%
1 Month Performance	9.02%	20.21%	-0.35%	-2.46%
1 Year Performance	32.77%	-4.57%	18.41%	13.66%

BioLife Solutions Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BLFS BioLife Solutions	2.6496 of 5 stars	$29.98 -2.6%	$31.43 +4.8%	+34.7%	$1.50B	$96.21M	N/A	440	Trending News Analyst Downgrade Analyst Revision
MMED MiniMed Group	2.6395 of 5 stars	$17.21 +1.7%	$21.33 +23.9%	N/A	$4.82B	$3.10B	N/A	8,000	News Coverage
LIVN LivaNova	2.0146 of 5 stars	$79.28 +0.1%	$81.38 +2.6%	+80.6%	$4.35B	$1.39B	40.65	3,300	News Coverage Analyst Upgrade
NVST Envista	2.4366 of 5 stars	$26.59 +0.0%	$28.54 +7.3%	+27.5%	$4.33B	$2.72B	64.87	12,000	News Coverage Positive News
IRTC iRhythm Technologies	4.1632 of 5 stars	$110.42 -0.9%	$186.62 +69.0%	-17.5%	$3.64B	$747.14M	N/A	2,400	News Coverage Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BLFS) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BioLife Solutions (BLFS) Competitors

BLFS vs. MMED, LIVN, NVST, IRTC, and ESTA

How does BioLife Solutions compare to MiniMed Group?

Summary

How does BioLife Solutions compare to LivaNova?

Summary

How does BioLife Solutions compare to Envista?

Summary

How does BioLife Solutions compare to iRhythm Technologies?

Summary

How does BioLife Solutions compare to Establishment Labs?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLFS vs. The Competition

BioLife Solutions Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BioLife Solutions (BLFS) Competitors

BLFS vs. MMED, LIVN, NVST, IRTC, and ESTA

How does BioLife Solutions compare to MiniMed Group?

Which has better valuation and earnings, MMED or BLFS?

Is MMED or BLFS more profitable?

Does the media refer more to MMED or BLFS?

Do analysts prefer MMED or BLFS?

Do insiders & institutionals believe in MMED or BLFS?

Summary

How does BioLife Solutions compare to LivaNova?

Does the media refer more to LIVN or BLFS?

Which has more volatility and risk, LIVN or BLFS?

Which has higher earnings & valuation, LIVN or BLFS?

Do insiders and institutionals believe in LIVN or BLFS?

Do analysts prefer LIVN or BLFS?

Is LIVN or BLFS more profitable?

Summary

How does BioLife Solutions compare to Envista?

Which has more volatility and risk, BLFS or NVST?

Which has preferable valuation and earnings, BLFS or NVST?

Do insiders & institutionals believe in BLFS or NVST?

Does the media favor BLFS or NVST?

Is BLFS or NVST more profitable?

Do analysts recommend BLFS or NVST?

Summary

How does BioLife Solutions compare to iRhythm Technologies?

Is IRTC or BLFS more profitable?

Do insiders and institutionals hold more shares of IRTC or BLFS?

Which has more volatility and risk, IRTC or BLFS?

Which has higher valuation & earnings, IRTC or BLFS?

Do analysts rate IRTC or BLFS?

Does the media refer more to IRTC or BLFS?

Summary

How does BioLife Solutions compare to Establishment Labs?

Is BLFS or ESTA more profitable?

Do insiders and institutionals have more ownership in BLFS or ESTA?

Which has more volatility and risk, BLFS or ESTA?

Do analysts rate BLFS or ESTA?

Which has stronger earnings & valuation, BLFS or ESTA?

Does the media favor BLFS or ESTA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLFS vs. The Competition

BioLife Solutions Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools